Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

Perrigo Company PLC might’ve been expected in its first quarterly results since launching its Opill OTC oral contraceptive in the US to highlight the early sales and the long-term impact from that historic US first.

Perrigo spared little about Opill’s launch, advertising and outlook in its first-quarter earnings briefing on 7 May, but management also made clear it’s a large firm and some other segments of its global